Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study

Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study

Abstract Background Biomarkers may contribute to our understanding of the pathophysiology of various diseases. Type 2 diabetes (T2D) and coronary heart disease (CHD) share many clinical and lifestyle risk factors and several biomarkers are associated with both diseases. The current analysis aims to...

Full description

Bibliographic Details
Main Authors: Cornelia Huth, Alina Bauer, Astrid Zierer, Julie Sudduth-Klinger, Christa Meisinger, Michael Roden, Annette Peters, Wolfgang Koenig, Christian Herder, Barbara Thorand
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Cardiovascular Diabetology
Subjects:
Type 2 diabetes
Coronary heart disease
Case-cohort study
Pathways
Biomarker
Fetuin-A
Online Access:http://link.springer.com/article/10.1186/s12933-020-01003-w

Internet

http://link.springer.com/article/10.1186/s12933-020-01003-w

Similar Items